Market Research Report
Defibrillator Market - Growth, Trends, and Forecasts (2020 - 2025)
|Published by||Mordor Intelligence Pvt Ltd||Product code||659348|
|Published||Content info||110 Pages
Delivery time: 2-3 business days
|Defibrillator Market - Growth, Trends, and Forecasts (2020 - 2025)|
|Published: August 1, 2020||Content info: 110 Pages||
The growth of the defibrillator market can be attributed to factors, such as technological advancements in the field of defibrillators and training and awareness programs for defibrillators. Recently, in 2020, Abbott Laboratories received a CE mark for its product "Gallant". It is an implantable cardioverter defibrillator (ICD) used in the prevention of sudden cardiac rhythm. Furthermore, the growing burden of cardiovascular diseases is expected to impact market growth.
According to the World Health Organization, in 2017, cardiovascular diseases were the leading cause of death, causing around 17.9 million deaths every year, globally. Hence, the increase in the prevalence of cardiovascular diseases is expected to drive market growth.
In the United States, approximately 300,000 out-of-hospital cardiac arrests occur, annually. Supportive government policies in developed countries may help increase the availability and access of defibrillators, which may further boost the market growth, over the forecast period.
Implantable Cardioverter Defibrillator (ICD) Spearheaded the Market Studied
North America is Expected to Dominate the Market Studied
The major players operating in the defibrillators market are Boston Scientific Corporation, Koninklijke Philips NV, Medtronic PLC, Nihon Kohden Corporation, and Abbott Laboratories. The key strategies adopted by the major market players are mergers, acquisitions, new product developments, geographical expansions, and enhanced marketing strategies.